Front Row Advisors LLC Danaher Corp Transaction History

Front Row Advisors LLC

  • $271 Million
  • Q3 2024

A detailed history of Front Row Advisors LLC transactions in Danaher Corp stock. As of the latest transaction made, Front Row Advisors LLC holds 12,481 shares of DHR stock, worth $2.93 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares
12,481
Previous 12,277 1.66%
Holding current value
$2.93 Million
Previous $3.07 Million 13.11%
% of portfolio
1.28%
Previous 1.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$239.25 - $280.76 $48,807 - $57,275
204 Added 1.66%
12,481 $3.47 Million
Q2 2024

Aug 15, 2024
SELL
$235.51 - $267.98 $271,778 - $309,248
-1,154 Reduced 8.59%
12,277 $3.07 Million
Q1 2024

May 14, 2024
BUY
$224.58 - $256.19 $2,245 - $2,561
10 Added 0.07%
13,431 $3.35 Million
Q4 2023

Feb 15, 2024
SELL
$185.1 - $233.13 $555 - $699
-3 Reduced 0.02%
13,421 $3.1 Million
Q3 2023

Nov 15, 2023
BUY
$233.08 - $265.59 $19,811 - $22,575
85 Added 0.64%
13,424 $3.33 Million
Q2 2023

Aug 14, 2023
SELL
$224.99 - $256.14 $47,922 - $54,557
-213 Reduced 1.57%
13,339 $3.21 Million
Q1 2023

May 22, 2023
BUY
$239.75 - $277.0 $2.43 Million - $2.81 Million
10,133 Added 296.37%
13,552 $3.42 Million
Q1 2023

May 15, 2023
SELL
$239.75 - $277.0 $2.44 Million - $2.82 Million
-10,165 Reduced 74.83%
3,419 $1.36 Million
Q4 2022

Feb 15, 2023
SELL
$241.42 - $282.29 $102,603 - $119,973
-425 Reduced 3.03%
13,584 $3.61 Million
Q3 2022

Nov 15, 2022
BUY
$247.06 - $1507.4 $1,235 - $7,537
5 Added 0.04%
14,009 $3.62 Million
Q2 2022

Aug 15, 2022
BUY
$237.11 - $299.66 $88,442 - $111,773
373 Added 2.74%
14,004 $3.55 Million
Q1 2022

May 11, 2022
BUY
$257.27 - $315.76 $21,867 - $26,839
85 Added 0.63%
13,631 $4 Million
Q4 2021

Mar 09, 2022
BUY
$292.08 - $329.01 $165,609 - $186,548
567 Added 4.37%
13,546 $4.46 Million
Q3 2021

Nov 03, 2021
BUY
$272.21 - $332.43 $34,026 - $41,553
125 Added 0.97%
12,979 $3.95 Million
Q2 2021

Aug 23, 2021
SELL
$225.08 - $271.69 $2,475 - $2,988
-11 Reduced 0.09%
12,854 $4.11 Million
Q1 2021

Apr 28, 2021
BUY
$212.38 - $245.9 $41,414 - $47,950
195 Added 1.54%
12,865 $2.9 Million
Q4 2020

Feb 25, 2021
SELL
$212.5 - $245.46 $11,687 - $13,500
-55 Reduced 0.43%
12,670 $2.82 Million
Q3 2020

Nov 30, 2020
SELL
$177.16 - $215.33 $113,382 - $137,811
-640 Reduced 4.79%
12,725 $2.76 Million
Q2 2020

Aug 17, 2020
SELL
$128.7 - $176.83 $32,303 - $44,384
-251 Reduced 1.84%
13,365 $2.37 Million
Q1 2020

May 08, 2020
BUY
$121.39 - $169.05 $95,412 - $132,873
786 Added 6.13%
13,616 $2.23 Million
Q4 2019

Feb 14, 2020
BUY
$133.47 - $153.48 $13,747 - $15,808
103 Added 0.81%
12,830 $1.97 Million
Q3 2019

Nov 08, 2019
BUY
$135.4 - $146.47 $39,266 - $42,476
290 Added 2.33%
12,727 $1.84 Million
Q2 2019

Aug 27, 2019
BUY
$124.88 - $143.73 $169,212 - $194,754
1,355 Added 12.23%
12,437 $1.78 Million
Q1 2019

May 17, 2019
SELL
$97.62 - $132.29 $2,928 - $3,968
-30 Reduced 0.27%
11,082 $1.47 Million
Q4 2018

Feb 13, 2019
BUY
$94.85 - $109.54 $13,753 - $15,883
145 Added 1.32%
11,112 $1.15 Million
Q3 2018

Nov 13, 2018
BUY
$98.13 - $108.9 $28,261 - $31,363
288 Added 2.7%
10,967 $1.05 Million
Q2 2018

Jul 31, 2018
BUY
$96.1 - $103.24 $86,970 - $93,432
905 Added 9.26%
10,679 $1.11 Million
Q1 2018

May 21, 2018
BUY
$92.16 - $103.8 $364,032 - $410,010
3,950 Added 67.82%
9,774 $957,000
Q4 2017

Feb 01, 2018
BUY
$85.26 - $94.62 $496,554 - $551,066
5,824
5,824 $541,000

Others Institutions Holding DHR

# of Institutions
2,508
Shares Held
539M
Call Options Held
7.07M
Put Options Held
4.55M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Front Row Advisors LLC Portfolio

Follow Front Row Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email